Head and Neck Cancer:

The rates of patients detected with HPV-related head and neck cancer is rising annually. By the passing of years, there will be more cases of HPV-related head and neck cancer than HPV-related cervical cancer. Number of studies have shown that most patients with this diagnosis are likely to be cured of their disease, placing an increased emphasis on quality of life and non-cancer outcomes in this population of survivors. The majority of patients diagnosed with HPV-related head and neck cancer are working people and it is a serious issue both financially and psychologically.

 How can treatment for Head and Neck Cancer impact employment?

Treatment for head and neck cancer involves a combination of chemotherapy and radiotherapy given over a six to seven week period, often known as chemo-radiotherapy. This process is considered as toxic and can impact a patient’s ability to function normally including speaking, chewing, breathing and swallowing. Many patients require number of supportive medications to get through treatment including narcotics for pain and anti-nausea medications. Patients losses on average of 10-15% of their weight within a few months and can suffer from severe fatigue and post-treatment depression.

For more information, contact:

Iris Jones 

Program Manager

Write your queries to headneck@oncologymeeting.org

For more information and registration, please visit:

https://headneck-treatment.conferenceseries.com/